vs
Kenvue（KVUE）与Raymond James Financial（RJF）财务数据对比。点击上方公司名可切换其他公司
Raymond James Financial的季度营收约是Kenvue的1.1倍（$4.2B vs $3.8B），Raymond James Financial净利率更高（13.5% vs 8.7%，领先4.8%），Raymond James Financial同比增速更快（3.5% vs 3.2%），Kenvue自由现金流更多（$744.0M vs $-56.0M），过去两年Raymond James Financial的营收复合增速更高（7.1% vs -1.5%）
Kenvue是美国消费者健康企业，前身为强生集团消费者健康业务部门，旗下拥有邦迪、李施德林、露得清、泰诺、强生婴儿、仙特明等诸多知名消费健康品牌，总部现位于美国新泽西州萨米特。
雷蒙德詹姆斯金融是美国跨国独立投资银行及金融服务机构，通过旗下子公司为个人、企业及市政主体提供多元金融服务，核心业务覆盖投资与财务规划、投资银行、资产管理等领域，总部位于美国佛罗里达州圣彼得堡。
KVUE vs RJF — 直观对比
营收规模更大
RJF
是对方的1.1倍
$3.8B
营收增速更快
RJF
高出0.3%
3.2%
净利率更高
RJF
高出4.8%
8.7%
自由现金流更多
KVUE
多$800.0M
$-56.0M
两年增速更快
RJF
近两年复合增速
-1.5%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $3.8B | $4.2B |
| 净利润 | $330.0M | $563.0M |
| 毛利率 | 56.5% | — |
| 营业利润率 | 14.2% | — |
| 净利率 | 8.7% | 13.5% |
| 营收同比 | 3.2% | 3.5% |
| 净利润同比 | 12.6% | -6.2% |
| 每股收益（稀释后） | $0.16 | $2.79 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收KVUERJF
| Q4 25 | $3.8B | $4.2B | ||
| Q3 25 | $3.8B | $4.2B | ||
| Q2 25 | $3.8B | $3.8B | ||
| Q1 25 | $3.7B | $3.8B | ||
| Q4 24 | $3.7B | $4.0B | ||
| Q3 24 | $3.9B | $4.0B | ||
| Q2 24 | $4.0B | $3.8B | ||
| Q1 24 | $3.9B | $3.6B |
净利润KVUERJF
| Q4 25 | $330.0M | $563.0M | ||
| Q3 25 | $398.0M | $604.0M | ||
| Q2 25 | $420.0M | $436.0M | ||
| Q1 25 | $322.0M | $495.0M | ||
| Q4 24 | $293.0M | $600.0M | ||
| Q3 24 | $383.0M | $602.0M | ||
| Q2 24 | $58.0M | $492.0M | ||
| Q1 24 | $296.0M | $476.0M |
毛利率KVUERJF
| Q4 25 | 56.5% | — | ||
| Q3 25 | 59.1% | — | ||
| Q2 25 | 58.9% | — | ||
| Q1 25 | 58.0% | — | ||
| Q4 24 | 56.5% | — | ||
| Q3 24 | 58.5% | — | ||
| Q2 24 | 59.1% | — | ||
| Q1 24 | 57.6% | — |
营业利润率KVUERJF
| Q4 25 | 14.2% | — | ||
| Q3 25 | 16.7% | — | ||
| Q2 25 | 18.0% | 14.7% | ||
| Q1 25 | 14.9% | 17.5% | ||
| Q4 24 | 13.2% | 18.6% | ||
| Q3 24 | 16.8% | — | ||
| Q2 24 | 3.9% | 17.1% | ||
| Q1 24 | 14.1% | 16.7% |
净利率KVUERJF
| Q4 25 | 8.7% | 13.5% | ||
| Q3 25 | 10.6% | 14.4% | ||
| Q2 25 | 10.9% | 11.3% | ||
| Q1 25 | 8.6% | 12.9% | ||
| Q4 24 | 8.0% | 14.9% | ||
| Q3 24 | 9.8% | 15.0% | ||
| Q2 24 | 1.5% | 13.1% | ||
| Q1 24 | 7.6% | 13.1% |
每股收益（稀释后）KVUERJF
| Q4 25 | $0.16 | $2.79 | ||
| Q3 25 | $0.21 | $2.96 | ||
| Q2 25 | $0.22 | $2.12 | ||
| Q1 25 | $0.17 | $2.36 | ||
| Q4 24 | $0.16 | $2.86 | ||
| Q3 24 | $0.20 | $2.85 | ||
| Q2 24 | $0.03 | $2.31 | ||
| Q1 24 | $0.15 | $2.22 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $1.1B | $9.9B |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $10.8B | $12.6B |
| 总资产 | $27.1B | $88.8B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资KVUERJF
| Q4 25 | $1.1B | $9.9B | ||
| Q3 25 | $1.1B | $11.4B | ||
| Q2 25 | $1.1B | $9.2B | ||
| Q1 25 | $1.1B | $9.7B | ||
| Q4 24 | $1.1B | $10.0B | ||
| Q3 24 | $1.1B | $11.0B | ||
| Q2 24 | $1.0B | $9.1B | ||
| Q1 24 | $1.2B | $10.0B |
股东权益KVUERJF
| Q4 25 | $10.8B | $12.6B | ||
| Q3 25 | $10.6B | $12.5B | ||
| Q2 25 | $10.7B | $12.3B | ||
| Q1 25 | $10.1B | $12.2B | ||
| Q4 24 | $9.7B | $11.9B | ||
| Q3 24 | $10.6B | $11.7B | ||
| Q2 24 | $10.2B | $11.2B | ||
| Q1 24 | $10.6B | $11.0B |
总资产KVUERJF
| Q4 25 | $27.1B | $88.8B | ||
| Q3 25 | $27.2B | $88.2B | ||
| Q2 25 | $27.1B | $84.8B | ||
| Q1 25 | $26.3B | $83.1B | ||
| Q4 24 | $25.6B | $82.3B | ||
| Q3 24 | $26.9B | $83.0B | ||
| Q2 24 | $26.4B | $80.6B | ||
| Q1 24 | $27.3B | $81.2B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $854.0M | $-10.0M |
| 自由现金流经营现金流 - 资本支出 | $744.0M | $-56.0M |
| 自由现金流率自由现金流/营收 | 19.7% | -1.3% |
| 资本支出强度资本支出/营收 | 2.9% | 1.1% |
| 现金转化率经营现金流/净利润 | 2.59× | -0.02× |
| 过去12个月自由现金流最近4个季度 | $1.7B | $1.4B |
8季度趋势，按日历期对齐
经营现金流KVUERJF
| Q4 25 | $854.0M | $-10.0M | ||
| Q3 25 | $294.0M | $796.0M | ||
| Q2 25 | $621.0M | $691.0M | ||
| Q1 25 | $428.0M | $117.0M | ||
| Q4 24 | $793.0M | $830.0M | ||
| Q3 24 | $249.0M | $510.0M | ||
| Q2 24 | $440.0M | $711.0M | ||
| Q1 24 | $287.0M | $391.0M |
自由现金流KVUERJF
| Q4 25 | $744.0M | $-56.0M | ||
| Q3 25 | $196.0M | $752.0M | ||
| Q2 25 | $533.0M | $634.0M | ||
| Q1 25 | $249.0M | $71.0M | ||
| Q4 24 | $661.0M | $789.0M | ||
| Q3 24 | $190.0M | $460.0M | ||
| Q2 24 | $350.0M | $655.0M | ||
| Q1 24 | $134.0M | $342.0M |
自由现金流率KVUERJF
| Q4 25 | 19.7% | -1.3% | ||
| Q3 25 | 5.2% | 17.9% | ||
| Q2 25 | 13.9% | 16.5% | ||
| Q1 25 | 6.7% | 1.8% | ||
| Q4 24 | 18.1% | 19.6% | ||
| Q3 24 | 4.9% | 11.5% | ||
| Q2 24 | 8.8% | 17.4% | ||
| Q1 24 | 3.4% | 9.4% |
资本支出强度KVUERJF
| Q4 25 | 2.9% | 1.1% | ||
| Q3 25 | 2.6% | 1.1% | ||
| Q2 25 | 2.3% | 1.5% | ||
| Q1 25 | 4.8% | 1.2% | ||
| Q4 24 | 3.6% | 1.0% | ||
| Q3 24 | 1.5% | 1.2% | ||
| Q2 24 | 2.3% | 1.5% | ||
| Q1 24 | 3.9% | 1.3% |
现金转化率KVUERJF
| Q4 25 | 2.59× | -0.02× | ||
| Q3 25 | 0.74× | 1.32× | ||
| Q2 25 | 1.48× | 1.58× | ||
| Q1 25 | 1.33× | 0.24× | ||
| Q4 24 | 2.71× | 1.38× | ||
| Q3 24 | 0.65× | 0.85× | ||
| Q2 24 | 7.59× | 1.45× | ||
| Q1 24 | 0.97× | 0.82× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
KVUE
| Self Care | $1.6B | 42% |
| Essential Health | $1.1B | 30% |
| Skin Health And Beauty | $1.0B | 28% |
RJF
暂无分部数据
